Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

AMG 837: A Novel GPR40/FFA1 Agonist that Enhances Insulin Secretion and Lowers Glucose Levels in Rodents

  • Daniel C.-H. Lin ,

    dclin@amgen.com

    Affiliation Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America

  • Jane Zhang,

    Affiliation Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America

  • Run Zhuang,

    Affiliation Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America

  • Frank Li,

    Affiliation Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America

  • Kathy Nguyen,

    Affiliation Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America

  • Michael Chen,

    Affiliation Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America

  • Thanhvien Tran,

    Affiliation Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America

  • Edwin Lopez,

    Affiliation Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America

  • Jenny Ying Lin Lu,

    Affiliation Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America

  • Xiaoyan Nina Li,

    Affiliation Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America

  • Liang Tang,

    Affiliation Pharmacokinetics and Drug Metabolism, Amgen Inc., South San Francisco, California, United States America

  • George R. Tonn,

    Affiliation Pharmacokinetics and Drug Metabolism, Amgen Inc., South San Francisco, California, United States America

  • Gayathri Swaminath,

    Affiliation Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America

  • Jeff D. Reagan,

    Affiliation Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America

  • Jin-Long Chen,

    Affiliation Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America

  • Hui Tian,

    Affiliation Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America

  • Yi-Jyun Lin,

    Affiliation Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America

  • Jonathan B. Houze,

    Affiliation Chemistry Research and Discovery, Amgen Inc., South San Francisco, California, United States America

  •  [ ... ],
  • Jian Luo

    Affiliation Metabolic Disorders, Amgen Inc., South San Francisco, California, United States of America

  • [ view all ]
  • [ view less ]

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.